Challenges in Endocrine Tumors
A special issue of Reports (ISSN 2571-841X).
Deadline for manuscript submissions: closed (28 February 2022) | Viewed by 619
Special Issue Editor
Interests: thyroid cancer; differentiated thyroid cancer; radioiodine-refractory thyroid cancer; medullary thyroid cancer; anaplastic thyroid cancer; endocrine neoplasms; neuroendocrine neoplasms; adrenocortical cancer; parathyroid cancer; pheochromocytoma/paraganglioma
Special Issue Information
Dear Colleagues,
The most common endocrine malignancy is papillary thyroid carcinoma, whose incidence has rapidly increased worldwide in the last thirty years, mainly due to extensive implementation of cancer screening and wide availability of neck ultrasound. By contrast, other types of thyroid cancers are rare diseases, including follicular, medullary, and anaplastic thyroid carcinoma as well as adrenocortical carcinoma, parathyroid carcinoma, malignant pheochromocytoma/paraganglioma, or neuroendocrine tumors. Endocrine tumors constitute a heterogeneous group and differ in clinical course, aggressiveness, hormonal activity and, finally, in diagnostic and therapeutic approaches.
Such a heterogeneous nature, on the one hand, and a rarity of the disease, on the other hand, give rise to the numerous diagnostic and therapeutic challenges we face in the clinic on a daily basis.
This Special Issue is a platform for sharing our experiences with endocrine tumors, demonstrating the difficulties associated with the diagnostics or treatment decision-making in these patients.
Dr. Jolanta Krajewska
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Reports is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- unusual presentation
- unusual disease course challenging differential diagnoses
- new treatment modalities
- therapeutic dilemmas
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
